In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.

Research shows those who later developed dementia performed significantly worse at the “triangle test” than those who ...

A new study published in Nature Medicine found that COVID-19 infection may lead to subtle changes in blood biomarkers tied to ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

For the first time, scientists from the University of Delaware College of Health Sciences and the National Institute on Aging (NIA) have shown that a natural dietary supplement called nicotinamide ...

Syracuse, NY -- Syracuse’s largest nursing home is entering a new frontier of research: allowing clinical trials on ...

Alzheimer's blood tests show accuracy gaps across populations, raising concerns about reliable diagnosis and healthcare inequality.

Several groundbreaking studies have examined the connection between hearing loss and Alzheimer’s risk: A Johns Hopkins ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Alzheimer’s disease (AD) is the most common type of dementia, affecting millions of people worldwide. It causes memory loss ...